Acasti Pharma reported $20.52M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Acasti Pharma USD 20.52M 8.58M Jun/2025
Addus HomeCare USD 263.04M 5.22M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
Cassava Sciences USD 114.82M 21.71M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Option Care Health USD 1.18B 75.85M Jun/2025
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Tilray USD 707.34M 18.54M Nov/2024